The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia.

IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Annals of Thoracic Medicine Pub Date : 2022-10-01 Epub Date: 2022-10-07 DOI:10.4103/atm.atm_156_22
Majid S Al-Thaqafy, Saleh Alzahrani, Abdulwahab Alghamdi, Saleh Alselemi, Khalid Alshebani, Bussma Ahmed Bugis, Alaa Bugis, Ali S Al-Shareef
{"title":"The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia.","authors":"Majid S Al-Thaqafy,&nbsp;Saleh Alzahrani,&nbsp;Abdulwahab Alghamdi,&nbsp;Saleh Alselemi,&nbsp;Khalid Alshebani,&nbsp;Bussma Ahmed Bugis,&nbsp;Alaa Bugis,&nbsp;Ali S Al-Shareef","doi":"10.4103/atm.atm_156_22","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Early use of a high-flow nasal cannula (HFNC) provides positive outcomes for preventing the risk of intubation. However, the efficiency and usage of HFNC in the case of coronavirus disease 2019 (COVID-19) among adult patients with multiple risk factors remain debatable and require more investigation.</p><p><strong>Aims: </strong>The aim of this study was to determine the efficiency of HFNC in preventing the possible risk of intubation.</p><p><strong>Settings and design: </strong>This study was an observational cross-sectional study that was conducted at a selected hospital in Jeddah, Saudi Arabia, from July 2020 to August 2021.</p><p><strong>Methods: </strong>The data were collected from patients' medical records through the hospital health information system. Adult COVID-19 patients who used HFNC were included, while those who used bilevel positive airway pressure or continuous positive airway pressure without any trials of HFNC and neonatal or pediatric patients were excluded. The exposure of HFNC setting which included variables such as percentages of the fraction of inspired oxygen and the duration of using HFNC were measured to find the relation with respiratory rate oxygenation (ROX) index as a measurement of patient outcome.</p><p><strong>Statistical analysis used: </strong>The data were analyzed by using the online calculator socscistatistics. com for prevalence statistics, and correlation tests of significance. Prevalence statistics were presented in mean, median, frequencies, and percentages. Statistical tests were used to measure correlations of key variables. <i>P</i> < 0.05 of ANOVA and <i>t</i>-tests was considered statistically significant.</p><p><strong>Results: </strong>A total of 159 adult COVID-19 patients using HFNC were included, and most of these patients were male. The median age was 64 years. Most of patients were reported to have hypertension and diabetes mellitus. The majority (94.34%) of patients were successfully weaned from HFNC and shows effective intervention with a mean of 7.53 of ROX score. Appropriate implementation of HFNC might be a successful intervention for preventing the risk of intubation.</p><p><strong>Conclusions: </strong>According to the success rate of HFNC, which was considered a positive outcome, there might be a promising intervention for HFNC to prevent the risk of intubation and decrease the mortality rate.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"17 4","pages":"214-219"},"PeriodicalIF":2.1000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/7e/ATM-17-214.PMC9662081.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Thoracic Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/atm.atm_156_22","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/7 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Early use of a high-flow nasal cannula (HFNC) provides positive outcomes for preventing the risk of intubation. However, the efficiency and usage of HFNC in the case of coronavirus disease 2019 (COVID-19) among adult patients with multiple risk factors remain debatable and require more investigation.

Aims: The aim of this study was to determine the efficiency of HFNC in preventing the possible risk of intubation.

Settings and design: This study was an observational cross-sectional study that was conducted at a selected hospital in Jeddah, Saudi Arabia, from July 2020 to August 2021.

Methods: The data were collected from patients' medical records through the hospital health information system. Adult COVID-19 patients who used HFNC were included, while those who used bilevel positive airway pressure or continuous positive airway pressure without any trials of HFNC and neonatal or pediatric patients were excluded. The exposure of HFNC setting which included variables such as percentages of the fraction of inspired oxygen and the duration of using HFNC were measured to find the relation with respiratory rate oxygenation (ROX) index as a measurement of patient outcome.

Statistical analysis used: The data were analyzed by using the online calculator socscistatistics. com for prevalence statistics, and correlation tests of significance. Prevalence statistics were presented in mean, median, frequencies, and percentages. Statistical tests were used to measure correlations of key variables. P < 0.05 of ANOVA and t-tests was considered statistically significant.

Results: A total of 159 adult COVID-19 patients using HFNC were included, and most of these patients were male. The median age was 64 years. Most of patients were reported to have hypertension and diabetes mellitus. The majority (94.34%) of patients were successfully weaned from HFNC and shows effective intervention with a mean of 7.53 of ROX score. Appropriate implementation of HFNC might be a successful intervention for preventing the risk of intubation.

Conclusions: According to the success rate of HFNC, which was considered a positive outcome, there might be a promising intervention for HFNC to prevent the risk of intubation and decrease the mortality rate.

Abstract Image

Abstract Image

沙特吉达地区成人冠状病毒covid - 19患者高流量鼻插管治疗效果观察
背景:早期使用高流量鼻插管(HFNC)为预防插管风险提供了积极的结果。然而,在具有多种危险因素的2019冠状病毒病(COVID-19)成年患者中,HFNC的有效性和使用情况仍存在争议,需要进一步调查。目的:本研究的目的是确定HFNC在预防可能的插管风险方面的效率。环境和设计:本研究是一项观察性横断面研究,于2020年7月至2021年8月在沙特阿拉伯吉达的一家选定医院进行。方法:通过医院卫生信息系统收集患者病历资料。纳入使用HFNC的成人COVID-19患者,排除未进行HFNC试验的双水平气道正压或持续气道正压患者以及新生儿或儿科患者。测量HFNC环境的暴露情况,包括吸入氧气的百分比和使用HFNC的时间等变量,以寻找与呼吸速率氧合(ROX)指数的关系,作为患者预后的衡量指标。使用的统计分析:使用在线计算器sociscistatistics对数据进行分析。Com进行流行率统计,并进行显著性相关检验。患病率统计以平均值、中位数、频率和百分比表示。采用统计学检验来衡量关键变量的相关性。方差分析和t检验的P < 0.05认为有统计学意义。结果:共纳入使用HFNC的成人COVID-19患者159例,其中以男性为主。中位年龄为64岁。大多数患者报告有高血压和糖尿病。大多数患者(94.34%)成功脱离HFNC,干预有效,ROX评分平均为7.53分。适当实施HFNC可能是预防插管风险的成功干预措施。结论:根据HFNC的成功率,这是一个积极的结果,可能有一个很有希望的干预措施,以防止插管风险,降低死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of Thoracic Medicine
Annals of Thoracic Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-RESPIRATORY SYSTEM
CiteScore
4.10
自引率
4.30%
发文量
19
审稿时长
>12 weeks
期刊介绍: The journal will cover studies related to multidisciplinary specialties of chest medicine, such as adult and pediatrics pulmonology, thoracic surgery, critical care medicine, respiratory care, transplantation, sleep medicine, related basic medical sciences, and more. The journal also features basic science, special reports, case reports, board review , and more. Editorials and communications to the editor that explore controversial issues and encourage further discussion by physicians dealing with chest medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信